EMERGENCY:Serious fall injury or swallowing emergency —call040-46324365immediately — 24 hours, 7 days— 24/7
Corticobasal Degeneration: When One Side of the Body Stops Obeying — and Sometimes Acts on Its Own
CBD is one of the rarest and most complex neurodegenerative conditions causing one-sided limb rigidity, apraxia, and in some patients, the extraordinary alien limb phenomenon. Expert diagnosis and specialist care at KIMS Neuroscience, Hyderabad.
CBD · Corticobasal Syndrome (CBS) · Atypical Parkinsonism
Neurodegenerative Disorders · Atypical Parkinsonism · Tauopathies
Movement Disorders · Neurology · Neuropsychology
Levodopa (limited benefit) · Botulinum toxin for dystonia · Physiotherapy · Speech therapy · Palliative care
Corticobasal Degeneration is a rare, progressive tauopathy causing degeneration of both the cerebral cortex and basal ganglia, producing a profoundly asymmetric syndrome: one limb becomes stiff, clumsy, and unable to perform purposeful actions (apraxia) despite having normal muscle strength. In some patients, the affected limb moves involuntarily and independently — the alien limb phenomenon. CBD presents in four clinical variants and is regularly mistaken for Parkinson's Disease, PSP, FTD, or Alzheimer's Disease. The definitive pathological diagnosis can only be confirmed at autopsy; during life, the clinical diagnosis is called Corticobasal Syndrome (CBS). Specialist assessment at KIMS with asymmetric cortical MRI and neuropsychological evaluation provides the most accurate available diagnosis.
- What it is
- Rare tauopathy causing asymmetric (one-sided) limb rigidity, apraxia, and in many patients the alien limb — a limb that moves involuntarily as if with its own will.
- The alien limb in plain terms
- The affected arm reaches for objects, grasps things, and interferes with the other hand — without the person wanting it to. A neurological phenomenon, not a psychiatric one.
- Apraxia explained
- Intact muscle strength but inability to perform purposeful actions with the affected hand (wave, use a key, brush teeth). The brain has lost the ability to programme the movement.
- Four clinical variants
- ~50% classic CBS (asymmetric rigidity + apraxia) · ~25% look like PSP · ~15% look like FTD · ~10% look like Alzheimer's. Same underlying disease, four clinical faces.
- CBS vs CBD
- CBS = the symptom pattern (diagnosable during life). CBD = the confirmed underlying pathology (confirmed at autopsy in <50% of CBS cases). Your neurologist is being precise, not vague.
- Most effective treatment
- Botulinum toxin for painful dystonic hand posturing (repeated every 3–4 months) · Clonazepam for myoclonus · Physiotherapy for falls · OT for home adaptation and daily function.
- Contact KIMS
- 040-44885000 · Movement disorders specialist · No referral required
| Fact | Details |
|---|---|
| Classification | Atypical parkinsonism · 4-repeat tauopathy · Cerebral cortex + basal ganglia |
| Hallmark | Profoundly asymmetric limb rigidity + apraxia · alien limb phenomenon in some patients |
| Apraxia | Normal strength but inability to programme purposeful movement in the affected hand |
| Four variants | ~50% classic CBS · ~25% PSP-like · ~15% FTD-like · ~10% Alzheimer's-like |
| CBS vs CBD | CBS = clinical syndrome (diagnosed during life) · CBD = confirmed pathology (at autopsy) |
| Treatment | Botulinum toxin (dystonic posturing) · Clonazepam (myoclonus) · Physiotherapy · Occupational therapy |
| Contact | 040-44885000 · Movement disorders specialist · No referral required |
About This Condition
What Is Corticobasal Degeneration?
Corticobasal Degeneration — CBD is one of the rarest and most diagnostically complex neurodegenerative conditions. It causes a slowly progressive loss of function in specific areas of the brain particularly the cerebral cortex (the outer layer of the brain that controls voluntary movement and higher thinking) and the basal ganglia (the deep brain structures that coordinate and fine-tune movement).
What makes CBD so distinctive and so difficult to diagnose is that its symptoms are almost always profoundly asymmetric at first. One side of the body is affected much more severely than the other. One arm becomes stiff, clumsy, and difficult to use purposefully. One hand may develop involuntary movements. The person may lose the ability to perform purposeful actions with one hand reaching correctly, using cutlery, writing even though the limb has the muscle strength to do so. This disconnect between intact muscle strength and lost ability to perform purposeful movement is called apraxia, and it is one of CBD's most characteristic features.
And then there is the alien limb phenomenon arguably the most extraordinary symptom in all of movement disorder neurology. In some patients with CBD, the affected arm begins to move involuntarily and purposelessly reaching for objects, interfering with the other hand, appearing to act with a will completely independent of the person's conscious intention. The person knows the arm is theirs, but it does not feel that way. Some patients describe having to physically restrain the arm with the other hand to stop it from interfering. It is deeply disturbing for patients and families, and it is one of the symptoms that most powerfully points toward CBD.
CBD is very rare affecting approximately 5 people per 100,000. There is no cure and no treatment that slows its progression. But an accurate diagnosis matters enormously for management planning, honest prognosis discussion, and ensuring the right symptom-specific interventions are in place.
At KIMS Neuroscience, Hyderabad, our specialist movement disorders team has the experience to diagnose CBD accurately which, given the complexity of this condition, requires more expertise than almost any other atypical Parkinsonian syndrome.
Book a Consultation
Speak directly with our specialist team. No referral required. Monday to Saturday.
040-44885000International enquiries: info@kimsneurosciences.comDiagnosis at KIMS
Why Is the Diagnosis Called "Corticobasal Syndrome" Rather Than CBD?
This is an important and honest clinical nuance that families should understand. When a neurologist describes the clinical picture of CBD the one-sided rigidity, the apraxia, the alien limb they are technically diagnosing something called Corticobasal Syndrome (CBS), not definitively CBD.
Why? Because less than half between 35% and 50% of patients presenting with the clinical picture of corticobasal syndrome during their lifetime are confirmed to have CBD at autopsy. The other cases, when the brain is examined after death, turn out to have other underlying pathologies most commonly PSP, Alzheimer's Disease, or Frontotemporal Dementia that happened to produce the same clinical pattern.
In plain terms: CBS is the symptom pattern. CBD is one of several underlying causes of that symptom pattern. During life, we can only diagnose the syndrome. The definitive cause is confirmed at post-mortem.
What this means practically for patients and families: when your neurologist says "corticobasal syndrome," they are not being vague or unhelpful. They are being precise. The management approach is the same regardless of the exact underlying pathology the symptoms are what we can treat, not the underlying cause. But understanding this distinction helps families have realistic expectations about diagnostic certainty.
What Are the Symptoms of Corticobasal Degeneration?
CBD's symptoms divide into three broad groups movement problems, cortical sensory problems, and cognitive or behavioural changes. In most patients, movement symptoms appear first, usually on one side of the body.
Movement Symptoms — Almost Always One-Sided at First
Rigidity and stiffness: The affected arm or leg becomes progressively stiff difficult to move passively, resisting being moved through its full range. This stiffness is often painful. It typically begins in one arm or hand and may remain predominantly one-sided for months to years before spreading to the other side.
Apraxia unable to perform purposeful actions despite having the strength to do so: Apraxia is the defining movement feature of CBD and one of the most important ways it differs from straightforward Parkinson's Disease. A person with apraxia has perfectly normal muscle strength in the affected limb, but loses the ability to organise and execute purposeful movements with it. They cannot correctly demonstrate how to wave goodbye, use a key, or brush their teeth with the affected hand even though the muscles work and they understand the instruction completely. This is not weakness. It is the loss of the brain's ability to programme the movement.
Dystonia involuntary sustained muscle contractions:The affected arm or hand may adopt abnormal postures involuntarily fingers curled inward, the hand held in a twisted position, the arm held rigidly against the body. This dystonia can be painful and can significantly limit hand function.
Myoclonus sudden brief jerks: Some CBD patients experience brief, sudden, shock-like jerks in the affected limb particularly in response to touch or movement. This is called stimulus-sensitive myoclonus and is another distinguishing feature of CBD.
The alien limb phenomenon: As described above the affected limb appears to move involuntarily and without the patient's conscious control. It may reach for objects, grasp items without intention, or interfere with the movement of the other hand. Over half of CBD patients experience an alien or useless arm. For families, this is often one of the most distressing symptoms to witness and one of the most important clues toward diagnosis.
Gait and balance: As the disease progresses to affect both sides, walking becomes increasingly difficult stiff, slow, and unsteady. Falls become a concern.
Cortical Sensory Problems — The “Cortical” in Corticobasal
This is the feature that distinguishes CBD most sharply from Parkinson's Disease and the other atypical Parkinsonian syndromes. The cerebral cortex processes what we feel not just temperature and pain, but the precise location of a touched object, the ability to identify an object by feel alone, and the sense of where the limb is in space.
In CBD, the affected limb may lose these refined sensory abilities:
Cortical sensory loss: The person cannot identify objects placed in the affected hand by touch alone (astereognosis), cannot identify numbers traced on the palm (agraphaesthesia), and may not be able to localise exactly where on the limb they are being touched.
Limb neglect: The affected limb may feel as if it does not belong to the person, or the person may pay insufficient attention to it related to the alien limb phenomenon.
Cognitive and Behavioural Symptoms
Although CBD was historically described purely as a motor disease, it is now recognised that cognitive and behavioural symptoms are also associated with CBD and often appear before the motor symptoms.
The cognitive profile of CBD is typically frontal-executive in character similar to FTD rather than a pure memory impairment like Alzheimer's:
• Difficulty with planning, organisation, and multitasking
• Slowed thinking and difficulty processing information quickly
• Word-finding difficulties particularly difficulty with naming
• In some patients, a full FTD-like behavioural syndrome with personality changes, disinhibition, and loss of empathy
Significant memory impairment of the Alzheimer's type is less common in early CBD but can occur in certain variants.
Speech and language: Speech in CBD may become slow, effortful, and dysarthric reflecting the motor aspects of the disease. Some patients develop a language problem called aphasia difficulty producing fluent language or understanding complex sentences reflecting cortical involvement.
Swallowing: As the disease progresses and both sides of the body become affected, swallowing difficulties develop increasing the risk of aspiration pneumonia, the most common cause of death in CBD.
What Are the Four Variants of Corticobasal Degeneration?
About half of all people with CBD have the classic corticobasal syndrome the archetype of CBD with asymmetric Parkinsonian and cortical features described above. About a quarter have an outward appearance that resembles PSP, with problems with balance, eye movement, speech and swallowing. Another 15% have a frontotemporal dementia presentation with behavioural changes. Two rare forms each about 5% present as Alzheimer's-like dementia.
This is why CBD is so consistently misdiagnosed, and why specialist expertise in atypical Parkinsonian conditions rather than general neurology is essential for identifying it correctly. The same underlying disease produces four completely different clinical pictures in different patients.
In Plain Terms for Families
• ~50% look like the "classic" CBD — one-sided rigidity, apraxia, and possible alien limb
• ~25% look like PSP — early falls, eye movement problems, axial rigidity
• ~15% look like FTD — personality and behaviour changes first, movement problems later
• ~10% look like Alzheimer's — memory and thinking problems predominating
What Causes CBD?
CBD is caused by the abnormal accumulation of tau protein in the brain specifically in both neurons and the surrounding support cells (astrocytes and oligodendrocytes) in the cerebral cortex and basal ganglia. Like PSP, CBD is classified as a 4-repeat tauopathy the form of tau that accumulates is a specific type (4R tau) that also accumulates in PSP. This is why CBD and PSP share some clinical overlap and are sometimes confused.
The underlying cause of this tau accumulation is not known. Most CBD cases are sporadic occurring without a family history. In rare cases, mutations in the MAPT gene (which encodes tau) are associated with CBD. Certain MAPT gene haplotypes increase the risk of both CBD and PSP, suggesting a shared genetic predisposition.
CBD is not directly inherited in most cases. Having a family member with CBD does not significantly increase your own risk.
How Is CBD Diagnosed at KIMS?
Diagnosing CBD is among the most challenging diagnostic exercises in movement disorder neurology. Because CBD signs and symptoms may be similar to other diseases such as Parkinson's Disease, it can be difficult to diagnose in the early stages and sometimes the diagnosis is only confirmed at autopsy.
At KIMS Neuroscience, Hyderabad, diagnosis follows a systematic specialist assessment.
Step 1: Clinical history focused on asymmetry and cortical features
The specialist will ask specifically about: • Which limb was first affected and how the problems began. • Whether the person has noticed involuntary movements of the affected limb particularly the alien limb phenomenon. • Difficulty performing precise purposeful actions with one hand despite having the muscle strength to do so (apraxia). • Abnormal posturing of the hand or arm (dystonia). • Brief sudden jerks in the affected limb (myoclonus). • Sensory changes in the affected limb numbness, tingling, or a sense that the limb does not feel normal. • How thinking memory or behaviour has changed alongside the movement problems. • The response to levodopa typically limited in CBD supporting the diagnosis.
Step 2: Neurological examination
The specialist examines specifically for: • The degree of asymmetry in rigidity and movement between sides. • Apraxia using a standardised battery of tests asking the person to perform specific actions with each hand. • Cortical sensory testing identifying objects by touch, localising tactile stimuli, identifying numbers traced on the palm. • Alien limb phenomenon observed during the examination. • Myoclonus assessed by touch and movement stimulation of the limb. • Eye movements to exclude the vertical gaze palsy that would suggest PSP. • Gait and balance assessment.
Step 3: Brain MRI — asymmetric cortical atrophy
MRI in CBD typically shows asymmetric atrophy of the posterior frontal and parietal cortex most prominent on the side opposite to the more severely affected limb. Asymmetrical frontoparietal atrophy is found in 87% of CBD patients compared to PSP patients making this MRI pattern one of the most useful imaging distinctions between the two conditions. The atrophy may be subtle in the early stages and requires a neurologist experienced in CBD to identify and interpret. At KIMS, our neurologists review MRI images specifically for this asymmetric atrophy pattern.
Step 4: Neuropsychological assessment
A comprehensive cognitive assessment documents the pattern of cognitive impairment helping to establish the variant of CBD and distinguish it from Alzheimer's Disease, FTD, and PSP. The asymmetric nature of cortical involvement in CBD often produces asymmetric cognitive deficits worse on the side corresponding to the more atrophied hemisphere which is a distinctive feature.
Step 5: FDG-PET scan (selected cases)
FDG-PET imaging shows characteristic asymmetric reduced metabolism in the frontal and parietal cortex often on one side that reflects the asymmetric cortical damage of CBD. It is used in diagnostically uncertain cases and can strongly support a CBD diagnosis.
Treatment
How Is CBD Treated at KIMS?
There is no cure for CBD and no treatment that slows its progression. There are no treatments that can stop or slow the progressive nature of CBD treatment is targeted at reducing symptoms, improving quality of life, and preventing complications.
Medications — limited but worth trying
Levodopa: A trial of levodopa is always reasonable in CBD both for any symptomatic benefit and because a poor response supports the diagnosis. In practice, most CBD patients experience little benefit. If there is a meaningful response, levodopa is continued.
Botulinum toxin injections for dystonia: This is often the most effective pharmacological intervention in CBD. When the affected hand or arm develops painful, fixed dystonic posturing, botulinum toxin injected into the overactive muscles can significantly reduce the dystonia improving comfort and allowing better hand cleaning and care. The injections need to be repeated every 3–4 months and are administered by our movement disorders team at KIMS.
Clonazepam for myoclonus: Benzodiazepines particularly clonazepam can reduce the severity of stimulus-sensitive myoclonus in the affected limb, improving comfort and reducing the disruptive jerking.
Antidepressants and anxiolytics: Depression and anxiety are common in CBD and respond to SSRIs. Addressing psychiatric symptoms significantly improves quality of life and the patient's ability to engage with rehabilitation.
Medications for cognitive symptoms: Unlike Alzheimer's Disease and Lewy Body Dementia, cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine are not useful in CBD the cognitive mechanism in CBD is different. The KIMS team will advise on the most appropriate approach to cognitive symptoms based on the specific variant and profile.
Physiotherapy falls prevention and maintaining mobility
Falls are a significant risk in CBD, particularly as the disease begins to affect both sides of the body. Our physiotherapy team provides: Specific balance and gait training tailored to the CBD pattern of movement impairment. Falls risk assessment and prevention strategies. Guidance on appropriate walking aids. Range-of-motion exercises for the affected limb, to reduce contractures as dystonia progresses. Home safety assessment in coordination with occupational therapy.
Occupational therapy maintaining function and independence
As apraxia progresses, the ability to perform daily tasks with the affected hand deteriorates. Our occupational therapist works with patients and families to: Develop compensatory strategies learning to perform tasks with the less-affected hand. Recommend adaptive equipment tools modified for single-hand use, large-grip utensils, and assistive devices. Assess the home for safety and recommend modifications. Advise on driving safety early CBD can affect the ability to drive safely, and this needs to be assessed and addressed.
Speech and language therapy
Both the motor speech difficulties (dysarthria) and any language difficulties (aphasia) in CBD are assessed and managed by our speech and language therapist. Communication strategies are developed early before speech deteriorates significantly and swallowing is monitored regularly for aspiration risk.
Managing the alien limb practical advice for families
There is no medication that stops the alien limb phenomenon. But there are practical strategies that help: Keeping the affected hand occupied with a soft object to hold giving it “something to do” can reduce the involuntary reaching. Wearing a glove or mittens on the affected hand can reduce tactile stimulation that triggers movements. Positioning keeping the limb in a supported, comfortable position during seated tasks reduces the opportunity for interference. Accepting the limb as part of the condition the neurologist can reassure the patient that this is a brain phenomenon, not a sign of “going mad.”
Palliative care from diagnosis
The same principle applies as in every condition on this list with a limited prognosis. CBD usually changes very slowly, and many people find it helpful to plan ahead with their doctors to make decisions about what to do in the later stages. Advance care planning the patient’s own documented wishes about future care, feeding, and medical decisions is most effective when done early. The KIMS palliative care team is available from diagnosis.
When Should You Seek a Specialist Assessment for CBD?
Come to KIMS Neuroscience, Hyderabad for specialist evaluation if the symptoms suggest Corticobasal Degeneration rather than typical Parkinson's Disease. Early specialist assessment helps ensure the right diagnosis, the right management plan, and timely support for both patients and families.
You do not need a referral letter. Appointments can be booked by calling 040-44885000 Monday to Saturday.
One arm or hand has become progressively stiff, difficult to use purposefully, or is adopting an abnormal fixed posture
An arm or hand appears to move on its own reaching for objects, interfering with the other hand, appearing to act independently
A person can no longer perform purposeful actions with one hand despite having the muscle strength to do so
There are brief, sudden jerks or spasms in one limb particularly triggered by touch
A person has been diagnosed with Parkinson's Disease but the symptoms are notably one-sided, the medication has not helped, and there are cortical sensory or apraxia features
A person has been diagnosed with PSP or FTD but one limb is particularly and severely more affected than the other
What to Expect — Living with CBD
On average, people live between six and eight years after the first symptoms of corticobasal degeneration appear. The disease progresses slowly but relentlessly, and the rate varies between individuals.
In the early stages often the first two to three years the disease is primarily one-sided, and many people continue to manage their daily lives with appropriate adaptations. The physiotherapy, occupational therapy, and speech therapy interventions begun early make the most difference in this window.
As the disease progresses and both sides become affected, the level of care required increases. The most serious complications aspiration pneumonia from swallowing difficulties, and fall injuries are the primary causes of death in CBD. Both are preventable or reducible with the right specialist management.
Planning ahead for care needs, for legal and financial arrangements, and for the patient's own wishes about future medical decisions is best done while cognitive function is preserved. The KIMS team will guide families through this process at an appropriate pace.
Related Conditions
Corticobasal Degeneration belongs to a broader family of neurodegenerative and movement-related disorders:
FAQs
Frequently Asked Questions
Has a family member's arm become stiff on one side or does it seem to move on its own without them wanting it to?
These are two of the most distinctive warning signs of Corticobasal Degeneration one of the rarest and most complex neurodegenerative conditions. At KIMS Neuroscience, Secunderabad, our specialist movement disorders team has the expertise to diagnose CBS/CBD accurately and to provide the specific symptom management this condition requires. You do not need a referral.
International enquiries: info@kimsneurosciences.com